Total Valuation
Samjin Pharmaceutical Co., Ltd. has a market cap or net worth of ₩211.25B. The enterprise value is $347.35K.
Market Cap₩211.25B
Enterprise Value$347.35K
Share Statistics
Samjin Pharmaceutical Co., Ltd. has 13,320,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,320,000
Owned by Insiders―
Owned by Institutions0.16%
Financial Efficiency
Samjin Pharmaceutical Co., Ltd.’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 5.73%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)5.73%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee377.45M
Profits Per Employee29.51M
Employee Count819
Asset Turnover0.66
Inventory Turnover1.41
Valuation Ratios
The current PE Ratio of Samjin Pharmaceutical Co., Ltd. is 9.5. Samjin Pharmaceutical Co., Ltd.’s PEG ratio is -0.27.
PE Ratio9.5
PS Ratio0.78
PB Ratio0.83
Price to Fair Value0.83
Price to FCF24.30
Price to Operating Cash Flow6.66
PEG Ratio-0.27
Income Statement
In the last 12 months, Samjin Pharmaceutical Co., Ltd. had revenue of 309.13B and earned 24.17B in profits. Earnings per share was 1.96K.
Revenue309.13B
Gross Profit153.03B
Operating Income24.68B
Pretax Income22.10B
Net Income24.17B
EBITDA44.50B
Earnings Per Share (EPS)1.96K
Cash Flow
In the last 12 months, operating cash flow was 33.83B and capital expenditures -7.90B, giving a free cash flow of 25.92B billion.
Operating Cash Flow33.83B
Free Cash Flow25.92B
Free Cash Flow per Share1.95K
Dividends & Yields
Samjin Pharmaceutical Co., Ltd. pays an annual dividend of $800, resulting in a dividend yield of ―
Dividend Per Share$800
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.14
52-Week Price Change-3.57%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Samjin Pharmaceutical Co., Ltd. upcoming earnings date is Nov 18, 2026, TBA (Confirmed).
Last Earnings DateAug 14, 2026
Next Earnings DateNov 18, 2026
Ex-Dividend Date―
Financial Position
Samjin Pharmaceutical Co., Ltd. as a current ratio of 1.30, with Debt / Equity ratio of 43.47%
Current Ratio1.30
Quick Ratio0.55
Debt to Market Cap0.56
Net Debt to EBITDA2.78
Interest Coverage Ratio4.99
Taxes
In the past 12 months, Samjin Pharmaceutical Co., Ltd. has paid -2.07B in taxes.
Income Tax-2.07B
Effective Tax Rate-0.09
Enterprise Valuation
Samjin Pharmaceutical Co., Ltd. EV to EBITDA ratio is 8.22, with an EV/FCF ratio of 36.73.
EV to Sales1.18
EV to EBITDA8.22
EV to Free Cash Flow36.73
EV to Operating Cash Flow16.45
Balance Sheet
Samjin Pharmaceutical Co., Ltd. has ₩20.88B in cash and marketable securities with ₩129.88B in debt, giving a net cash position of -₩109.01B billion.
Cash & Marketable Securities₩20.88B
Total Debt₩129.88B
Net Cash-₩109.01B
Net Cash Per Share-₩8.18K
Tangible Book Value Per Share₩21.94K
Margins
Gross margin is 45.63%, with operating margin of 7.98%, and net profit margin of 7.82%.
Gross Margin45.63%
Operating Margin7.98%
Pretax Margin7.15%
Net Profit Margin7.82%
EBITDA Margin14.40%
EBIT Margin7.98%
Analyst Forecast
The average price target for Samjin Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast0.28%
EPS Growth Forecast16.80%